Stip E, Lussier I
Centre de recherche Fernand-Seguin, Hôpital Louis-H Lafontaine, Montréal, QC.
Can J Psychiatry. 1996 Oct;41(8 Suppl 2):S35-40. doi: 10.1177/070674379604100802.
To evaluate the effect of risperidone on cognitive functions after both 6 weeks and 6 months of treatment and to determine whether any improvement on neuropsychological function relates to improvement in psychopathology.
Patients' psychiatric and extrapyramidal symptoms were assessed while they were receiving classical neuroleptic treatment and adjunctive medications. Patients were then reassessed after changing to a new treatment of risperidone.
During treatment with risperidone, schizophrenic patients displayed improved performance mainly on attentional components, specifically, selective attention and alertness.
In patients who were given risperidone, there was a positive correlation between improvement in psychopathology and improvement in cognitive tests of explicit memory and alertness.
评估利培酮治疗6周和6个月后对认知功能的影响,并确定神经心理功能的任何改善是否与精神病理学的改善相关。
在患者接受经典抗精神病药物治疗和辅助药物治疗时,评估其精神症状和锥体外系症状。然后在改为利培酮新治疗后对患者进行重新评估。
在利培酮治疗期间,精神分裂症患者主要在注意力成分上表现出改善,特别是选择性注意力和警觉性。
在接受利培酮治疗的患者中,精神病理学的改善与外显记忆和警觉性的认知测试的改善之间存在正相关。